Approval · Notice of Compliance 5701 · 1994
HAVRIX: Notice of Compliance 5701
Issued June 17, 1994
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5701
- Date
- June 17, 1994
- Company
- Smithkline Beecham Pharma, Division Of Smithkline Beecham Inc.Mississauga, Ontario, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Active immunizing agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| HAVRIX | 02108216 | Cancelled Post Market |
Medicinal ingredients
- HEPATITIS A VACCINE, INACTIVATED 720 UNIT per ML